Ionis Pharmaceuticals (IONS) PT Raised at Bernstein Following 'Positive Topline Results'
Tweet Send to a Friend
Bernstein SocGen Group analyst William Pickering raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $50.00 (from $42.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
